These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35187768)

  • 1. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris with advanced hypopharyngeal and gastric cancer following SARS-CoV-2 vaccination.
    Norimatsu Y; Yoshizaki A; Yamada T; Akiyama Y; Toyama S; Sato S
    J Dermatol; 2023 Feb; 50(2):e74-e75. PubMed ID: 35906790
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases with new onset of pemphigus foliaceus after SARS-CoV-2 vaccination.
    Rouatbi J; Aounallah A; Lahouel M; Sriha B; Belajouza C; Denguezli M
    Dermatol Ther; 2022 Nov; 35(11):e15827. PubMed ID: 36111460
    [No Abstract]   [Full Text] [Related]  

  • 6. De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.
    Saffarian Z; Samii R; Ghanadan A; Vahidnezhad H
    Dermatol Ther; 2022 Jun; 35(6):e15448. PubMed ID: 35289040
    [No Abstract]   [Full Text] [Related]  

  • 7. Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report.
    Khalayli N; Omar A; Kudsi M
    J Med Case Rep; 2023 Jul; 17(1):322. PubMed ID: 37496035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe aggravation and possible triggering of pemphigus vulgaris following COVID-19 vaccination: report of two cases.
    Irie K; Yamamoto T
    An Bras Dermatol; 2024; 99(5):758-762. PubMed ID: 38834398
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
    Falcinelli F; Lamberti A; Cota C; Rubegni P; Cinotti E
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e976-e978. PubMed ID: 35789506
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.
    Martora F; Fabbrocini G; Nappa P; Megna M
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e750-e751. PubMed ID: 35679165
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.
    Rasner CJ; Schultz B; Bohjanen K; Pearson DR
    J Med Case Rep; 2023 Sep; 17(1):408. PubMed ID: 37749657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination.
    Ligrone L; Lembo S; Cillo F; Spennato S; Fabbrocini G; Raimondo A
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1369-e1371. PubMed ID: 37561928
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
    Fitzpatrick S; Cha S; Katz J; Migliorati C
    Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into new-onset autoimmune diseases after COVID-19 vaccination.
    Guo M; Liu X; Chen X; Li Q
    Autoimmun Rev; 2023 Jul; 22(7):103340. PubMed ID: 37075917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study.
    Arduino PG; Kubanov AA; Vlasova AV; Martynov AA; Svishchenko SI; Petti S
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e374-e376. PubMed ID: 38217309
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.
    Solimani F; Mansour Y; Didona D; Dilling A; Ghoreschi K; Meier K
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e649-e651. PubMed ID: 34169588
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine.
    Koutlas IG; Camara R; Argyris PP; Davis MDP; Miller DD
    Oral Dis; 2022 Nov; 28 Suppl 2():2612-2613. PubMed ID: 34825752
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
    J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus foliaceus triggered after inactivated SARS-CoV-2 vaccine: Coincidence or causal link?
    Alami S; Benzekri L; Senouci K; Meziane M
    Dermatol Ther; 2022 Oct; 35(10):e15775. PubMed ID: 35976680
    [No Abstract]   [Full Text] [Related]  

  • 20. Sarcoidal immune reaction following SARS-CoV-2 vaccination.
    Abu Rached N; Mansour R; Susok L; Fried S; Abolmaali N; Lee YP; Gambichler T
    Clin Exp Dermatol; 2022 May; 47(5):970-972. PubMed ID: 34978352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.